Pharma & Healthcare Mutual Funds in India specialize in investing in pharmaceutical companies, biotechnology firms, and related healthcare industries.
Long Horizon
20 Funds
₹30,163 Cr Total AUM
Sort By
Fund name | Fund size | Expense Ratio | 3Y Returns |
---|---|---|---|
SBI Healthcare Opportunities Fund Direct Growth Sector - Healthcare Very High Risk | ₹3,416 Cr | 0.89% | 24.3% |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth Sector - Healthcare Very High Risk | ₹5,024 Cr | 1.09% | 24.2% |
DSP Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹3,138 Cr | 0.59% | 22.9% |
Tata India Pharma & Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹1,208 Cr | 0.69% | 21.1% |
UTI Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹1,187 Cr | 1.28% | 21.0% |
ITI Pharma and Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹208 Cr | 0.47% | 20.8% |
Nippon India Pharma Fund Direct Growth Sector - Healthcare Very High Risk | ₹8,688 Cr | 0.91% | 19.5% |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹881 Cr | 0.92% | 18.9% |
Mirae Asset Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹2,770 Cr | 0.49% | 18.7% |
LIC MF Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹80 Cr | 1.21% | 17.4% |
Identify red flags in your mutual funds and how to fix them
By Market Cap
By Diversification
By Sectors & Themes
By Solutions
Invest in mid-sized companies in their growth phase
Invest in the largest 250 companies in India
Invest in the largest 100 companies in India
Invest in small-sized companies in their growth phase
Tracks a market index
Hybrid funds are a combination of equity and debt investments. The blend of these asset classes varies based on the fund's investment goals.
Debt Mutual Funds invest in fixed-income securities such as government bonds, corporate bonds, treasury bills, and other money market instruments.